Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis

Fuhrman, C.; Jougla, E.; Nicolau, J.; Eilstein, D.; Delmas, M-C.
November 2006
Thorax;Nov2006, Vol. 61 Issue 11, p930
Academic Journal
Background: A study was undertaken of deaths with an underlying or associated cause of chronic obstructive pulmonary disease (COPD), and trends in COPD mortality from 1979 to 2002 in France were analysed. Methods: Data were obtained from the Centre of Epidemiology on the Medical Causes of Death (CépiDc) for individuals aged 45 years and over. Owing to implementation of lCD-10 in 2000 for recording causes of death, two separate periods were analysed (1979–99 and 2000–2). Results: In 2000–2, COPD was the underlying cause of 1.4% of deaths (deaths from COPD) and was mentioned on the death certificate in 3.0% (deaths with COPD). The other main underlying causes in these cases were cardiovascular diseases (32.0%) and cancers (24.5%). In 1979–99, age standardised rates of death with COPD remained stable in men (-0.01%/year) and increased in women (+1.7%/year). The mean annual rates of death with COPD per 100 000 were 84 for men and 19 for women in 2000–2. Conclusion: Multiple cause analysis improved the estimate of COPD related mortality. In 1979–99, COPD related mortality rates in France were stable in men but increased in women. Implementation of lCD-10 in 2000 introduced substantial discontinuities in mortality trends.


Related Articles

  • Target COPD and reduce heart disease morbidity and death. Castaneda, Reynald // New Zealand Doctor;8/28/2013, p13 

    The article offers the insights of Neil Barnes, respiratory and general medicine consultant at London Chest Hospital in New Zealand, regarding the importance of treating chronic obstructive pulmonary disease (COPD) for the reduction of cardiovascular disease morbidity and mortality.

  • FEV1 Is a Better Predictor of Mortality than FVC: The PLATINO Cohort Study. Menezes, Ana Maria B.; Pérez-Padilla, Rogelio; Wehrmeister, Fernando César; Lopez-Varela, Maria Victorina; Muiño, Adriana; Valdivia, Gonzalo; Lisboa, Carmen; Jardim, José Roberto B.; de Oca, Maria Montes; Talamo, Carlos; Bielemann, Renata; Gazzotti, Mariana; Laurenti, Ruy; Celli, Bartolomé; Victora, Cesar G. // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Objective: To determine whether the presence of chronic obstructive lung disease (COPD) and reduction of lung function parameters were predictors of mortality in a cohort. Materials/Patients and Methods: Population based cohorts were followed in Montevideo, Santiago and Sao Paulo during 5, 6...

  • The Relation of Serum Myeloperoxidase to Disease Progression and Mortality in Patients with Chronic Obstructive Pulmonary Disease (COPD). Park, Hye Yun; Man, S. F. Paul; Tashkin, Donald; Wise, Robert A.; Connett, John E.; Anthonisen, Nicholas A.; Sin, Don D. // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    Myeloperoxidase is a strong oxidant stored in primary granules of neutrophils with potent antibacterial and proatherogenic properties. Myeloperoxidase has been implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, the relationship of myeloperoxidase to health...

  • Mortality attributable to occupational exposure in Sweden. Järvholm, Bengt; Reuterwall, Christina; Bystedt, Jennie // Scandinavian Journal of Work, Environment & Health;Jan2013, Vol. 39 Issue 1, p106 

    Objective The aim of this study was to estimate the mortality from cancer, cardiovascular, and respiratory diseases attributable to occupational exposure in Sweden. Methods Estimates were calculated for men and women separately, and we considered only deaths between 25-74 years of age. We...

  • Nocturnal deaths among patients with chronic bronchitis and emphysema. McNicholas, Walter T.; Fitzgerald, Muiris X. // British Medical Journal (Clinical Research Edition);10/6/1984, Vol. 289 Issue 6449, p878 

    Examines the incidence of nocturnal deaths among patients with chronic bronchitis and emphysema in Great Britain. Comparison on mortality pattern between day and night period; Impact of flow oxygen support on the decrease of nocturnal deaths; Advice on the care of patients with chronic...

  • Handgrip weakness and mortality risk in COPD: a multicentre analysis. Burtin, Chris; ter Riet, Gerben; Puhan, Milo A.; Waschki, Benjamin; Garcia-Aymerich, Judith; Pinto-Plata, Victor; Celli, Bartolome; Watz, Henrik; Spruit, Martijn A. // Thorax;Jan2016, Vol. 71 Issue 1, p86 

    The article discusses an analysis of to identify role of handgrip strength in mortality of patients suffering with chronic obstructive pulmonary disease (COPD).

  • Developing COPD: a 25 year follow up study of the general population. Løkke, A.; Lange, P.; Scharling, H.; Fabricius, P.; Vestbo, J. // Thorax;Nov2006, Vol. 61 Issue 11, p935 

    Background: Smokers are more prone to develop chronic obstructive pulmonary disease (COPD) than non-smokers, but this finding comes from studies spanning 10 years or less. The aim of this study was to determine the 25 year absolute risk of developing COPD in men and women from the general...

  • Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD): ECG changes and Cardiovascular work-up. Lane, Cheryl; Wong, Alyson; Burns, Jane; Sin, Don; van Eeden, Stephan F. // UBC Medical Journal;Apr2011, Vol. 2 Issue 2, p24 

    PURPOSE: Risk factors for and cardiovascular disease (CVD) are common in subjects with Chronic Obstructive Pulmonary Disease (COPD) and predicts morbidity and all-cause mortality in COPD patients. Here we determine how patients are investigated for exacerbation of CVD in subjects admitted with...

  • Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Dransfield, M T; Rowe, S M; Johnson, J E; Bailey, W C; Gerald, L B // Thorax;Apr2008, Vol. 63 Issue 4, p301 

    Background: Cardiovascular disease is a major cause of death in patients with chronic obstructive pulmonary disease (COPD) and predicts hospitalisation for acute exacerbation, in-hospital death and post-discharge mortality. Although β blockers improve cardiovascular outcomes, patients with...


Read the Article


Sign out of this library

Other Topics